[go: up one dir, main page]

LV12658A - Dry powder active agent pulmonary delivery - Google Patents

Dry powder active agent pulmonary delivery

Info

Publication number
LV12658A
LV12658A LV010041A LV010041A LV12658A LV 12658 A LV12658 A LV 12658A LV 010041 A LV010041 A LV 010041A LV 010041 A LV010041 A LV 010041A LV 12658 A LV12658 A LV 12658A
Authority
LV
Latvia
Prior art keywords
active agent
dry powder
pulmonary delivery
powder active
agent pulmonary
Prior art date
Application number
LV010041A
Other languages
English (en)
Other versions
LV12658B (lv
Inventor
Andrew Clark
Mei-Chang Kuo
Celily Lalor
Barry John Aldous
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Publication of LV12658A publication Critical patent/LV12658A/lv
Publication of LV12658B publication Critical patent/LV12658B/lv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
LV010041A 1998-09-14 2001-03-14 Sausa aktivas vielas pulvera ievadisanas panemiens plausas LV12658B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (2)

Publication Number Publication Date
LV12658A true LV12658A (lv) 2001-05-20
LV12658B LV12658B (lv) 2001-09-20

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
LV010041A LV12658B (lv) 1998-09-14 2001-03-14 Sausa aktivas vielas pulvera ievadisanas panemiens plausas

Country Status (44)

Country Link
EP (1) EP1117442A1 (lv)
JP (1) JP2002524535A (lv)
KR (1) KR20010075063A (lv)
CN (1) CN1317977A (lv)
AP (1) AP1374A (lv)
AR (1) AR022090A1 (lv)
AU (1) AU753014B2 (lv)
BG (1) BG105430A (lv)
BR (1) BR9913722A (lv)
CA (1) CA2343920A1 (lv)
CO (1) CO5130023A1 (lv)
CZ (1) CZ2001829A3 (lv)
DZ (1) DZ2892A1 (lv)
EA (1) EA003476B1 (lv)
EE (1) EE200100151A (lv)
GE (1) GEP20043257B (lv)
GT (1) GT199900156A (lv)
HK (1) HK1042231A1 (lv)
HN (1) HN1999000159A (lv)
HR (1) HRP20010189A2 (lv)
HU (1) HUP0103837A3 (lv)
ID (1) ID28845A (lv)
IL (2) IL141562A0 (lv)
IS (1) IS5878A (lv)
LT (1) LT4897B (lv)
LV (1) LV12658B (lv)
MA (1) MA25590A1 (lv)
MY (1) MY129282A (lv)
NO (1) NO20011251L (lv)
NZ (1) NZ510168A (lv)
OA (1) OA11781A (lv)
PA (1) PA8481901A1 (lv)
PE (1) PE20001061A1 (lv)
PL (1) PL195574B1 (lv)
SA (1) SA99200718B1 (lv)
SK (1) SK3442001A3 (lv)
TN (1) TNSN99173A1 (lv)
TR (1) TR200101182T2 (lv)
TW (1) TWI226248B (lv)
UA (1) UA76085C2 (lv)
UY (1) UY25711A1 (lv)
WO (1) WO2000015262A1 (lv)
YU (1) YU24201A (lv)
ZA (1) ZA200101995B (lv)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
JP4874483B2 (ja) 1999-06-09 2012-02-15 ロバート イー. シーバース 超臨界流体補助ネブライゼーション及びバブル乾燥
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
EG24184A (en) 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
CA2465675C (en) 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
UA83341C2 (uk) 2002-02-25 2008-07-10 Дифьюжен Фармасьютикалз Ллк Біополярні солі транс-каротиноїдів та їх використання
AU2003232081B2 (en) * 2002-07-03 2009-02-05 Brandeis University Central airway administration for systemic delivery of therapeutics
CA2511385A1 (en) * 2002-12-19 2004-07-22 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
ES2909080T3 (es) 2004-04-23 2022-05-05 Cydex Pharmaceuticals Inc Formulación de DPI que contiene sulfoalquil éter ciclodextrina
US8030350B2 (en) 2005-02-24 2011-10-04 Diffusion Pharmaceuticals Llc Trans carotenoids, their synthesis, formulation and uses
BRPI0608844A2 (pt) * 2005-03-09 2010-02-02 Ono Pharmaceutical Co partìcula e preparação que contém a partìcula
ES2526903T3 (es) 2005-10-26 2015-01-16 Cydex Pharmaceuticals, Inc. Composiciones de sulfoalquiléter ciclodextrina y métodos de preparación de las mismas
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20080035143A1 (en) * 2006-08-14 2008-02-14 Sievers Robert E Human-powered dry powder inhaler and dry powder inhaler compositions
KR20090081407A (ko) * 2006-10-25 2009-07-28 다이닛본 스미토모 세이야꾸 가부시끼가이샤 고결 방지 과립상 제제
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
MX2009010988A (es) 2007-04-13 2010-03-15 Diffusion Pharmaceuticals Llc Uso de trans-carotenoides bipolares como un tratamiento previo y en el tratamiento de una enfermedad vascular periferica.
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
MX2010004803A (es) 2007-10-31 2010-09-09 Diffusion Pharmaceuticals Llc Una nueva clase de composiciones terapeuticas que mejoran la difusion de moleculas pequeñas.
US9610343B2 (en) * 2009-05-20 2017-04-04 Aeras Global Tb Vaccine Foundation Stable, spray dryed, immunogenic, viral compositions
EP2445339B1 (en) 2009-06-22 2019-08-07 Diffusion Pharmaceuticals LLC Diffusion enhancing compound and its use with a thrombolytic
ES2654945T3 (es) 2010-06-02 2018-02-15 Diffusion Pharmaceuticals Llc Formulaciones orales de carotenoides trans bipolares
US9682096B2 (en) 2012-05-02 2017-06-20 Janssen R & D Ireland Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
WO2015042352A1 (en) * 2013-09-20 2015-03-26 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
CA2965759C (en) 2014-10-31 2023-12-12 Glaxosmithkline Intellectual Property Development Limited Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials
WO2017165667A1 (en) 2016-03-24 2017-09-28 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
ATE222754T1 (de) * 1992-06-12 2002-09-15 Teijin Ltd Ultrafeines pulver zur inhalation und dessen herstellung
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
WO1998031346A1 (en) * 1997-01-16 1998-07-23 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
UA76085C2 (en) 2006-07-17
IS5878A (is) 2001-03-05
CN1317977A (zh) 2001-10-17
IL141562A0 (en) 2002-03-10
HUP0103837A3 (en) 2002-11-28
CZ2001829A3 (cs) 2001-09-12
KR20010075063A (ko) 2001-08-09
TWI226248B (en) 2005-01-11
PL346768A1 (en) 2002-02-25
EP1117442A1 (en) 2001-07-25
ZA200101995B (en) 2002-03-11
HUP0103837A2 (hu) 2002-05-29
BG105430A (en) 2001-12-29
AP2001002093A0 (en) 2001-03-31
TR200101182T2 (tr) 2001-09-21
CO5130023A1 (es) 2002-02-27
MY129282A (en) 2007-03-30
GT199900156A (es) 2001-03-07
WO2000015262A1 (en) 2000-03-23
HRP20010189A2 (en) 2005-04-30
PE20001061A1 (es) 2000-10-08
IL141562A (en) 2007-07-24
TNSN99173A1 (fr) 2005-11-10
SA99200718B1 (ar) 2006-11-04
AR022090A1 (es) 2002-09-04
CA2343920A1 (en) 2000-03-23
BR9913722A (pt) 2001-05-29
LT2001021A (en) 2001-11-26
PA8481901A1 (es) 2002-04-25
UY25711A1 (es) 1999-11-17
AP1374A (en) 2005-02-28
LT4897B (lt) 2002-02-25
EA003476B1 (ru) 2003-06-26
ID28845A (id) 2001-07-05
LV12658B (lv) 2001-09-20
NO20011251L (no) 2001-04-17
HK1042231A1 (zh) 2002-08-09
SK3442001A3 (en) 2001-11-06
JP2002524535A (ja) 2002-08-06
AU753014B2 (en) 2002-10-03
EE200100151A (et) 2002-06-17
MA25590A1 (fr) 2002-12-31
GEP20043257B (en) 2004-06-25
OA11781A (en) 2005-07-26
DZ2892A1 (fr) 2003-12-15
AU6039799A (en) 2000-04-03
EA200100300A1 (ru) 2001-10-22
NO20011251D0 (no) 2001-03-13
PL195574B1 (pl) 2007-10-31
YU24201A (sh) 2003-08-29
HN1999000159A (es) 1999-11-11
NZ510168A (en) 2003-09-26

Similar Documents

Publication Publication Date Title
LV12658A (lv) Dry powder active agent pulmonary delivery
DE60035911D1 (de) Trockenpulverinhalator
MA26033A1 (fr) Agent active de livraison aerosol
DE60141579D1 (de) Trockenpulver-Inhalator
DE69935008D1 (de) Hydrofluorether enthaltende trockenreinigungsmittel
IS4364A (is) Innöndunarbúnaður fyrir þurrduft
NO20035654D0 (no) System for avlevering av törrpulverformuleringer
EP0927025A4 (en) DRY POWDER COMPOSITION WITH ACTIVE INGREDIENT ENCLOSED IN LIPOSOMES
NO992339D0 (no) Farmas°ytiske formuleringer
FR2780857B1 (fr) Agent pesticide
DK1073417T3 (da) Farmaceutisk aerosolformulering
DE69908568D1 (de) Herbizid aktive 3-hydroxy-4-aryl-5-oxopyrazolinderivate
NO20003721D0 (no) Farmasøytisk aktivt morfolinol
HUP0104483A3 (en) Fungicidal active substance combinations and use thereof
IS2004B (is) Lyfjasamsetningar sem innihalda vorikónasól
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
DE69925167D1 (de) Hochwitterungsbeständige pulverlackzusammensetzung
PT1227724E (pt) Agente herbicida
NO985341D0 (no) Formulering omfattende mikropartikler for inhalering
DE59902159D1 (de) Aktiver mikromischer
DE69905278D1 (de) Insectizide mittel
IT1291823B1 (it) Composti pseudo-peptidici, loro preparazione ed uso in formulazioni farmaceutiche
NO20004816D0 (no) Ny farmasøytisk formulering
DE60034215D1 (de) Oberflaechenaktive zusammensetzung
EP1157700A4 (en) ANTI-HIV SUBSTANCE